| (INR) | Jun 2026 | Y/Y change |
|---|---|---|
| Revenue | 25.80B | — |
| Operating expense | — | — |
| Net income | 2.94B | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, EMCURE.NS returned +24.1% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | +35.8% |
| 1 year | +24.1% |
| All-time high | ₹1,960.10 (Jul 2026) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what ₹1,000 in EMCURE.NS would be worth today ›No. Emcure Pharmaceuticals Limited has not paid a dividend in the past 12 months.
Emcure Pharmaceuticals Limited is part of the Healthcare sector.
Emcure Pharmaceuticals Limited has a market cap of 350.32B INR, based on the latest quote.
